Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Turlure

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Leukemia|April 7, 2011
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidineR Itzykson, S Thépot, V Eclache, et al.
Leukemia|July 16, 2011
Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemiaA Renneville, N Boissel, N Helevaut, et al.
Pathologie-Biologie|September 10, 2013
[Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report]J-O Bay, R Peffault de Latour, B Bruno, et al.
Pathologie-Biologie|July 13, 2014
[Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC]S Belaiche, N Yafour, S Balcaen, et al.
Pathologie-Biologie|September 10, 2013
[Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report]M-T Rubio, A Charbonnier, E de Berranger, et al.
Leukemia|January 27, 2006
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemiaD Rea, L Legros, E Raffoux, et al.
Pathologie-Biologie|June 24, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]S Nguyen, D Blaise, J-O Bay, et al.
Pathologie-Biologie|July 6, 2014
[Prophylactic, preemptive and curative use of donor lymphocyte infusion in patients undergoing allogeneic stem cell transplantation: guidelines of the SFGM-TC]T Guillaume, S Porcheron, F Audat, et al.
Leukemia Research|December 20, 2011
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?R Itzykson, S Thépot, O Beyne-Rauzy, et al.
Leukemia|October 20, 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa groupA-L Taksin, O Legrand, E Raffoux, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Leukemia|April 7, 2011
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidineR Itzykson, S Thépot, V Eclache, et al.
Leukemia|July 16, 2011
Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemiaA Renneville, N Boissel, N Helevaut, et al.
Pathologie-Biologie|September 10, 2013
[Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report]J-O Bay, R Peffault de Latour, B Bruno, et al.
Pathologie-Biologie|July 13, 2014
[Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC]S Belaiche, N Yafour, S Balcaen, et al.
Pathologie-Biologie|September 10, 2013
[Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report]M-T Rubio, A Charbonnier, E de Berranger, et al.
Leukemia|January 27, 2006
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemiaD Rea, L Legros, E Raffoux, et al.
Pathologie-Biologie|June 24, 2014
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)]S Nguyen, D Blaise, J-O Bay, et al.
Pathologie-Biologie|July 6, 2014
[Prophylactic, preemptive and curative use of donor lymphocyte infusion in patients undergoing allogeneic stem cell transplantation: guidelines of the SFGM-TC]T Guillaume, S Porcheron, F Audat, et al.
Leukemia Research|December 20, 2011
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?R Itzykson, S Thépot, O Beyne-Rauzy, et al.
Leukemia|October 20, 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa groupA-L Taksin, O Legrand, E Raffoux, et al.
Pageof 5